Enzon Pharmaceuticals Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy Signal from Moving Average: Indicates potential upward movement.
Sell Signal (MA)
Sell Signal from Moving Average: Indicates potential downward movement.
AI Analysis of ENZN
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Enzon Pharmaceuticals stock price took a fall of -21.32% on Friday
(Updated on Oct 04, 2024)
Sell candidate since Oct 04, 2024
The Enzon Pharmaceuticals stock price fell by -21.32% on the last day (Friday, 4th Oct 2024) from $0.140 to $0.110. During the last trading day the stock fluctuated 0% from a day low at $0.110 to a day high of $0.110. The price has fallen in 4 of the last 10 days and is down by -9.09% for this period. Volume has increased on the last day by 716 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $188.76 .
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.107 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -26.48% during the next 3 months and, with a 90% probability hold a price between $0.0785 and $0.105 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ENZN Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, September 30, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enzon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.117 and $0.136. A break-up above any of these levels will issue buy signals. Enzon Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Enzon Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ENZN) For The Upcoming Trading Day Of Monday 7th
For the upcoming trading day on Monday, 7th we expect Enzon Pharmaceuticals to open at $0.110, and during the day (based on 14 day Average True Range), to move between $0.101 and $0.119, which gives a possible trading interval of +/-$0.0088 (+/-7.96%) up or down from last closing price. If Enzon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 15.92% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $0.120, some $0.0100 (9.09%) from the current price of $0.110, our system finds the risk reward not very attractive.
Is Enzon Pharmaceuticals stock A Buy?
Enzon Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.
Current score:
-5.375
Strong Sell Candidate
Downgraded
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 7, 2024 - $0.110 ( 0%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for ENZN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.110 | - |
| R2 | 0.110 | - |
| R1 | 0.110 | - |
| Price | 0.110 | |
| S1 | 0.110 | - |
| S2 | 0.110 | - |
| S3 | 0.110 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.135 | 22.73% |
| R2 | 0.130 | 18.18% |
| R1 | 0.120 | 9.09% |
| Price | 0.110 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
ENZN Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Sep 30, 2019 | Sep 30, 2019 | Oct 15, 2019 | $0.120 | 52.17% |
| 2 | Feb 20, 2019 | Feb 20, 2019 | Feb 20, 2019 | $0.0600 | 26.09% |
| 3 | Sep 29, 2017 | Sep 29, 2017 | Sep 29, 2017 | $0.150 | 62.51% |
| 4 | Dec 13, 2016 | Dec 13, 2016 | Dec 13, 2016 | $0.150 | 44.72% |
| 5 | Dec 30, 2015 | Dec 30, 2015 | Dec 30, 2015 | $0.250 | 36.23% |
FAQ
Click here for our free guide on how to buy Enzon Pharmaceuticals Stock.
